Trial Profile
The Safety, Tolerability, and Immunogenicity of Three Dose Levels of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine, in Adults Without Previous Smallpox Vaccination
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs MVA 3000 (Primary) ; Smallpox vaccine
- Indications Smallpox
- Focus Adverse reactions
- Sponsors Sanofi; Sanofi Pasteur
- 16 Jan 2014 New source identified and integrated (ClinicalTrials.gov record; NCT00079820)
- 05 Nov 2010 New trial record.